SymBio Pharmaceuticals Limited (TYO:4582)
Japan · Delayed Price · Currency is JPY 69.00
+3.00 (4.55%)
Jul 31, 2026, 3:30 PM JST
SymBio Pharmaceuticals Ratios and Metrics
Market cap in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,978 | 5,024 | 9,121 | 10,421 | 25,399 | 43,941 | |
Market Cap Growth | -35.31% | -44.92% | -12.48% | -58.97% | -42.20% | 203.74% |
Enterprise Value | 4,108 | 3,900 | 3,992 | 4,307 | 19,266 | 41,327 |
Last Close Price | 69.00 | 90.00 | 199.00 | 247.00 | 643.00 | 1145.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 21.54 | 21.62 |
PS Ratio | 3.90 | 3.84 | 3.72 | 1.87 | 2.54 | 5.32 |
PB Ratio | 21.49 | 3.96 | 2.17 | 1.45 | 2.99 | 6.51 |
P/TBV Ratio | 21.49 | 3.96 | 2.17 | 1.45 | 3.07 | 6.77 |
P/FCF Ratio | - | - | - | - | 15.76 | 383.47 |
P/OCF Ratio | - | - | - | - | 15.74 | 313.77 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.22 | 2.98 | 1.63 | 0.77 | 1.93 | 5.01 |
EV/EBITDA Ratio | - | - | - | - | 9.34 | 37.23 |
EV/EBIT Ratio | - | - | - | - | 9.81 | 40.68 |
EV/FCF Ratio | - | - | - | - | 11.95 | 360.66 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 4.43 | 1.56 | - | - | - | - |
Net Debt / Equity Ratio | -3.76 | -0.71 | -0.94 | -0.90 | -0.74 | -0.57 |
Net Debt / EBITDA Ratio | - | - | 1.05 | 9.13 | -3.04 | -3.48 |
Net Debt / FCF Ratio | - | 0.20 | 1.15 | 16.37 | -3.90 | -33.69 |
Asset Turnover | 0.34 | 0.30 | 0.37 | 0.60 | 1.06 | 1.12 |
Inventory Turnover | 1.63 | 1.37 | 2.46 | 3.36 | 5.64 | 3.69 |
Quick Ratio | 0.80 | 2.44 | 5.73 | 7.77 | 4.35 | 3.96 |
Current Ratio | 1.11 | 2.96 | 6.43 | 8.45 | 4.84 | 4.45 |
Return on Equity (ROE) | -322.67% | -174.78% | -67.22% | -24.97% | 15.46% | 35.64% |
Return on Assets (ROA) | -92.14% | -62.83% | -36.89% | -5.46% | 13.00% | 8.62% |
Return on Invested Capital (ROIC) | - | -1477.87% | -838.27% | -55.69% | 43.05% | 55.00% |
Return on Capital Employed (ROCE) | -1667.50% | -172.30% | -92.30% | -11.30% | 23.10% | 14.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -117.64% | -95.07% | -42.02% | -18.83% | 4.64% | 4.63% |
FCF Yield | -91.90% | -91.06% | -37.66% | -3.82% | 6.35% | 0.26% |
Buyback Yield / Dilution | -19.47% | -11.34% | -13.02% | -0.75% | -1.97% | -17.88% |